Ascendis Pharma Announces Commencement of Ordinary Share Trading on Nasdaq Following ADS Exchange

Ascendis Pharma A/S announced that as of April 20, 2026, its ordinary shares have commenced trading on The Nasdaq Global Select Market. This listing replaces the company's previous listing of American Depositary Shares (ADSs). The ordinary shares will continue to trade under the ticker symbol 'ASND'. This transition follows the company's April 8, 2026, announcement regarding a mandatory exchange of all outstanding ADSs for ordinary shares on a one-for-one basis. The final day of trading for the ADSs on Nasdaq was April 17, 2026. As of the effective date, all outstanding ADSs have been exchanged for ordinary shares. The ordinary shares are identified by CUSIP number K08588103 and ISIN DK0060606333. This administrative shift streamlines the company's equity structure on the Nasdaq exchange without changing its ticker identity.